Vetter and Rentschler Biopharma, two globally operating contract development and manufacturing organizations (CDMOs), have formed a collaboration to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain. With drug development growing increasingly complex and cost-intensive, biopharmaceutical companies are under significant pressure to streamline their products’ path to market. The desired goal of the collaboration is to create long-term valu...